Artificial Intelligence and its future potential in lung cancer screening

dc.contributor.authorJoy Mathew, Christopher
dc.contributor.authorDavid, Ashwini Maria
dc.contributor.authorJoy Mathew, Chris Mariya
dc.date.accessioned2020-12-17T14:11:23Z
dc.date.available2020-12-17T14:11:23Z
dc.date.issued2020-12-11
dc.description.abstractArtificial intelligence (AI) simulates intelligent behavior as well as critical thinking comparable to a human being and can be used to analyze and interpret complex medical data. The application of AI in imaging diagnostics reduces the burden of radiologists and increases the sensitivity of lung cancer screening so that the morbidity and mortality associated with lung cancer can be decreased. In this article, we have tried to evaluate the role of artificial intelligence in lung cancer screening, as well as the future potential and efficiency of AI in the classification of nodules. The relevant studies between 2010-2020 were selected from the PubMed database after excluding animal studies and were analyzed for the contribution of AI. Techniques such as deep learning and machine learning allow automatic characterization and classification of nodules with high precision and promise an advanced lung cancer screening method in the future. Even though several combination models with high performance have been proposed, an effectively validated model for routine use still needs to be improvised. Combining the performance of artificial intelligence with a radiologist’s expertise offers a successful outcome with higher accuracy. Thus, we can conclude that higher sensitivity, specificity, and accuracy of lung cancer screening and classification of nodules is possible through the integration of artificial intelligence and radiology. The validation of models and further research is to be carried out to determine the feasibility of this integration.en
dc.identifier.citationoy Mathew, C., David, A. M., & Joy Mathew, C. M. (2020). Review article - Artificial Intelligence and its future potential in lung cancer screening. EXCLI Journal, 19, 1552-1562. https://doi.org/10.17179/excli2020-3095de
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/39920
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21810
dc.language.isoen
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmundde
dc.relation.ispartofseriesEXCLI Journal;Vol. 19. 2020, pp. 1552-1562
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectArtificial intelligenceen
dc.subjectLung neoplasmsen
dc.subjectEarly detection of canceren
dc.subjectMachine learningen
dc.subjectLung cancer screeningen
dc.subjectArtificial intelligence and lung canceren
dc.subjectLow-dose computed tomographyen
dc.subjectArtificial intelligence in radiologyen
dc.subjectComputer-aided diagnosisen
dc.subjectConvolutional neural networks (cnn)en
dc.subject.ddc610
dc.titleArtificial Intelligence and its future potential in lung cancer screeningen
dc.title.alternativereview articleen
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1
eldorado.dnb.zdberstkatidtrue
eldorado.identifier.urlhttps://www.excli.de/index.php/excli/article/view/3095

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
excli2020-3095.pdf
Size:
814.58 KB
Format:
Adobe Portable Document Format
Description:
DNB
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.85 KB
Format:
Item-specific license agreed upon to submission
Description: